Bixiye
QP25-24 Appeal Submission Timeframe Alignment
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2024
Natiijooyinka Raadinta
Soo bandhiga 821 - 830 ee natiijooyinka 4295
Bixiye
QP26-24 Commercial Pharmacy Benefit Exclusion for Amtagvi®
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2024
Bixiye
QP27-24 MHCP Pharmacy Benefit Exclusion for Amtagvi® and Pemrydi RTU™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2024
Bixiye
QP24-24 Telehealth Place of Service Code 10 Changed to Non-Facility
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2024
Bixiye
QP20-24 Provider Press: Q1 2024
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2024
Bixiye
QP21-24 Update for New to Market Medical Drugs: DONANEMAB
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2024
Bixiye
QP22-24 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2024
Bixiye
QP23-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective April 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2024
Bixiye
2024 March Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2024
Bixiye
P19-24 Availity is Assisting Providers Impacted by Change HealthCare Cybersecurity Incident
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2024